Skip to main content
OpenTrials

Clinical trial condition

Bipolar Disorder

Explore clinical trials studying Bipolar Disorder. Study availability and eligibility vary by location and protocol.

1,280 public trials 156 recruiting studies
Refine in advanced search Browse all conditions

Bipolar Disorder trial results

Completed

3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects

NCT00312494

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Mental Disorders, +1 more
Locations
  • Pfizer Investigational Site Dothan, Alabama, United States
  • Pfizer Investigational Site Scottsdale, Arizona, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Cerritos, California, United States
View all 66 locations
View Trial Details
Completed

A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression

NCT00141271

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Mental Disorders, +1 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Dana Point, California, United States
  • Pfizer Investigational Site La Mesa, California, United States
  • Pfizer Investigational Site Laguna Hills, California, United States
View all 72 locations
View Trial Details
Completed

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

NCT00280566

Conditions
Bipolar Disorder, Bipolar Mania, Bipolar and Related Disorders, +2 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Scottsdale, Arizona, United States
View all 107 locations
View Trial Details
Completed

Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)

NCT00265330

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Mental Disorders, +1 more
Locations
  • Pfizer Investigational Site Scottsdale, Arizona, United States
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site Aurora, Colorado, United States
  • Pfizer Investigational Site Altamonte Springs, Florida, United States
View all 41 locations
View Trial Details
Completed

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression

NCT03965871

Conditions
Bipolar Depression, Bipolar Disorder, Bipolar and Related Disorders, +2 more
Locations
  • Wojewodzki Szpital im. Jana Pawła II Bełchatów, Poland
  • Wojewodzki Szpital dla Nerwowo i Psychicznie Chorych Bolesławiec, Poland
  • Samodzielny Publiczny Psychiatryczny Zaklad Opieki Zdrowotnej Choroszcz, Poland
  • Szpital Miejski Elblag, Poland
View Trial Details
Completed

Wake Therapy in the Treatment of Depression

NCT01431573

Conditions
Behavior, Behavioral Symptoms, Bipolar Disorder, +7 more
Locations
  • Depression Evaluation Service - New York State Psychiatric Institute New York, United States
  • New York State Psychiatric Institute New York, United States
View Trial Details
Completed

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

NCT00483548

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Depression, Bipolar, +2 more
Locations
  • Pfizer Investigational Site Chandler, Arizona, United States
  • Pfizer Investigational Site Litchfield Park, Arizona, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
  • Pfizer Investigational Site Little Rock, Arkansas, United States
View all 70 locations
View Trial Details
Completed

Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)

NCT00257166

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Mental Disorders, +1 more
Locations
  • Pfizer Investigational Site Scottsdale, Arizona, United States
  • Pfizer Investigational Site Orange, California, United States
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site Denver, Colorado, United States
View all 50 locations
View Trial Details
Completed

A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders

NCT00650611

Conditions
Bipolar Disorder, Bipolar and Related Disorders, Mental Disorders, +5 more
Locations
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site Altamonte Springs, Florida, United States
  • Pfizer Investigational Site Libertyville, Illinois, United States
  • Pfizer Investigational Site Lexington, Kentucky, United States
View all 17 locations
View Trial Details

Related conditions